Coronavirus: Situation in Switzerland

Data and reports on the epidemiological situation in Switzerland and Liechtenstein, press conferences and coronavirus news can all be found here.

Press conference, 14 April 2021, 4.30pm

Figures on the coronavirus situation in Switzerland and Liechtenstein

On www.covid19.admin.ch you’ll find the key figures on laboratory-confirmed cases, hospitalisations, deaths, tests, vaccinations, relevant virus variants, Re values, contact tracing (isolation and quarantine), hospital capacity and the international situation.

Deaths in connection with COVID-19

This report provides information and graphs on various statistics relating to deaths. It covers the period from March 2020 to February 2021. You will find statistics, updated on an ongoing basis, at covid19.admin.ch.

COVID-19 vaccination statistics

Twice a week, statistics on COVID-19 vaccination are published on www.covid19.admin.ch, where you’ll find the following figures:

  • Received vaccine doses
  • Vaccine doses delivered to cantons and FL
  • Administered vaccine doses
  • Fully vaccinated people

Allocation of vaccine doses to the cantons

Doses of vaccine are divided between the cantons in proportion to their population and share of especially vulnerable people (target group 1). This allocation is done on the basis of a distribution key. The distribution key for cantonal vaccine quotas was created by the Swiss Federal Institute of Technology (ETH) Zurich and the ZHAW Zurich University of Applied Sciences. The key takes account of population numbers from the Federal Statistical Office (SFSO) and the relevant target group’s share of the population. In this document you’ll find an explanation of the distribution key and an example.

In the following document you’ll find the allocation of cantonal vaccine quotas for especially vulnerable people (target group 1).

Vaccination scenarios

In the first quarter 2021 the federal government expected smaller volumes of vaccines. This vaccine was used to protect people in especially vulnerable groups as quickly as possible. Switzerland expects large volumes of vaccine in the second quarter of 2021. Everyone wishing to be vaccinated will thus have access to a COVID-19 vaccination by summer 2021.

By the end of March, 2.25 million doses of vaccine arrived in Switzerland. From April to the end of July 2021 Switzerland should receive 8.1 million doses of vaccine from Pfizer and Moderna combined – 3 million of them in May and 3 million in June. Switzerland expects further authorisations of vaccines.

According to the federal government’s vaccination scenario, assuming that 75% of people in vulnerable groups and 60% of the remaining adult population wish to be vaccinated, everyone wanting the vaccination will have received at least one dose by the end of June.

The speed with which each target population group can be vaccinated depends on the willingness of people within the group to be vaccinated and the vaccination capacity in the cantons. You will find different vaccination scenarios in this document:

COVID-19 management: Strategic basis at federal and cantonal level

The federal government and the cantons have interrelated tasks in the management of COVID-19. This results in a need to coordinate assessments, reconcile measures and define processes. This brief strategy paper sets out to clarify the basic principles governing these issues over the months to come. The aim is to protect the health of the population in Switzerland and minimise the impact of the outbreak and spread of the coronavirus as far as possible.

COVID-19 management: Strategic bases of the Swiss Conference of the Cantonal Ministers of Public Health (GDK) and the FDHA-FOPH (in German (PDF, 768 kB, 22.10.2020) and French (PDF, 779 kB, 22.10.2020))

Monitoring and interim reports 

On the Monitoring page you will find reports on the population’s mobility behaviour, the monitoring of precautionary measures, the economic situation and compliance monitoring.

Study on the spread and impact of the new coronavirus

When someone is infected with the new coronavirus, their body produces specific antibodies in the blood. Through detection of these antibodies, we can determine how many people in the population have been infected.
A nationwide long-term monitoring programme seeks to provide insights into the spread and impact of coronavirus. It is being conducted as part of Corona Immunitas, a national science programme of the Swiss School of Public Health (SSPH+).

Objectives of the programme

The detection of antibodies seeks to:

  • provide evidence on the spread of coronavirus in Switzerland’s different regions and in specific population and occupational groups;
  • provide information on whether and to what extent measures to combat the spread of coronavirus are working;
  • determine whether a past infection protects from re-infection and if so, how long this protection lasts.

Surveys aim to deliver insights into the impact of coronavirus in terms of:

  • our day-to-day lives in the community,
  • our behaviour,
  • our health.

Programme: participation, scope and duration

Fourteen universities and institutions from all over Switzerland are participating in Corona Immunitas. Over 40 studies are being conducted involving more than 30,000 Swiss residents.

Corona Immunitas will run until the end of 2021.

The FOPH is contributing to the study and providing financial support. The findings will provide an important basis to help federal and cantonal policymakers determine what measures are needed to combat the coronavirus epidemic.

Scientific task force

The Swiss National COVID-19 Science Task Force (SN-STF) serves as a scientific advisory body to the federal government. Its members are researchers from across the entire university landscape. The SN-STF contributes to efforts to manage the coronavirus pandemic by making its scientific and research expertise available to the political authorities responsible.

The task force is headed by Professor Martin Ackermann (ETH Zurich and Eawag) together with a steering committee comprising Dr Urs Karrer (Winterthur cantonal hospital), Professor Jan-Egbert Sturm (KOF Swiss Economic Institute, ETH Zurich) and Professor Samia Hurst (University of Geneva).

The SN-STF has been mandated by the Federal Department of Home Affairs (FDHA) and the FOPH.

Further information may be found on the website of the Swiss National COVID-19 Science Task Force.

FOPH COVID-19 Task Force

The focus of the FOPH COVID-19 Task Force is managing the crisis and its consequences for people in Switzerland.

The FOPH COVID-19 Task Force comprises the following: the Director-General of the FOPH and her staff; representatives of the General Secretariat of the Federal Department of Home Affairs (GS-FDHA), the Federal Civil Protection Crisis Management Board and the State Secretariat for Economic Affairs (SECO); the Commissioner of the Federal Council for the Coordinated Medical Service; and, when needed, representatives of additional federal agencies and heads of FOPH working groups formed in response to the coronavirus.

The FOPH COVID-19 Task Force meets (digitally) several times a week. Below you will find the minutes of its meetings from November 2020 (in German). To avoid influence on current decisions, minutes are not published until a month after the meeting.

More information on the FOPH COVID-19 Task Force.

Most recent published minutes of the FOPH COVID-19 Task Force:

February 2021 minutes (PDF, 9 MB, 13.04.2021) (in German)

January 2021 minutes (PDF, 9 MB, 11.03.2021) (in German)

December 2020 minutes (PDF, 9 MB, 25.02.2021) (in German)

November 2020 minutes (PDF, 10 MB, 25.02.2021) (in German)

Further information

Monitoring

Current reports on the population’s mobility behaviour, implementation of the precautionary measures and the economic situation.

Last modification 15.04.2021

Top of page

Contact

Federal Office of Public Health FOPH
Infoline Coronavirus
Tel. +41 58 463 00 00

Print contact

Are you experiencing symptoms? Take the coronavirus check! Click here.
https://www.bag.admin.ch/content/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/situation-schweiz-und-international.html